{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:07:31Z","timestamp":1788001651854,"version":"build-2784847793"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009017","name":"ALS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["143275"],"award-info":[{"award-number":["143275"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00737","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:18:44Z","timestamp":1757629124000},"page":"e00737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS"],"prefix":"10.1016","volume":"22","author":[{"given":"Am\u00e9lie","family":"Poulin-Bri\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurot.2025.e00737_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 pathology in Alzheimer's disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"5796","key":"10.1016\/j.neurot.2025.e00737_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00737_bib4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awz078","article-title":"The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?","volume":"142","author":"Hergesheimer","year":"2019","journal-title":"Brain : J Neurol"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00737_bib5","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00737_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00702-018-1851-y","article-title":"Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis","volume":"125","author":"Br\u00e4uer","year":"2018","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurot.2025.e00737_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.conb.2019.11.018","article-title":"Prion-like properties of assembled TDP-43","volume":"61","author":"Nonaka","year":"2020","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","article-title":"Prion-like properties of pathological TDP-43 aggregates from diseased brains","volume":"4","author":"Nonaka","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2025.e00737_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.790114","article-title":"Antibody-based therapeutic interventions for amyotrophic lateral sclerosis: a systematic literature review","volume":"15","author":"Poulin-Bri\u00e8re","year":"2021","journal-title":"Front Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.neurot.2025.e00737_bib11","doi-asserted-by":"crossref","first-page":"24178","DOI":"10.18632\/oncotarget.4680","article-title":"Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00737_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nrl.2013.08.001","article-title":"Cellular changes in motor neuron cell culture produced by cytotoxic cerebrospinal fluid from patients with amyotrophic lateral sclerosis","volume":"29","author":"Gomez-Pinedo","year":"2014","journal-title":"Neurologia"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-016-0698-0","article-title":"Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"13","author":"Mishra","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-017-1028-x","article-title":"Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia","volume":"14","author":"Mishra","year":"2017","journal-title":"J Neuroinflamm"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40478-020-00943-4","article-title":"Transmission of ALS pathogenesis by the cerebrospinal fluid","volume":"8","author":"Mishra","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2009.09.009","article-title":"Altered neuronal activities in the motor cortex with impaired motor performance in adult rats observed after infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"206","author":"Sankaranarayani","year":"2010","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00737_bib17","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.031997","article-title":"Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model","volume":"11","author":"Shanmukha","year":"2018","journal-title":"Dis Model Mech"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00737_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.nbd.2010.12.005","article-title":"Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients","volume":"41","author":"Vijayalakshmi","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurot.2025.e00737_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainres.2009.01.041","article-title":"Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line","volume":"1263","author":"Vijayalakshmi","year":"2009","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00737_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac207","article-title":"Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis","volume":"4","author":"Wong","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurot.2025.e00737_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2011.09.025","article-title":"CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole","volume":"1423","author":"Y\u00e1\u00f1ez","year":"2011","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00737_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.mehy.2015.07.014","article-title":"Amyotrophic lateral sclerosis: is the spinal fluid pathway involved in seeding and spread?","volume":"85","author":"Smith","year":"2015","journal-title":"Med Hypotheses"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00737_bib23","first-page":"293","article-title":"El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler : Off Publ World Fed Neurol Res Group Motor Neuron Diseases"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00737_bib24","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1093\/brain\/awr159","article-title":"Pathological hallmarks of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments","volume":"134","author":"Swarup","year":"2011","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00737_bib25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI123931","article-title":"Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology","volume":"129","author":"Pozzi","year":"2019","journal-title":"J Clin Investig"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00737_bib26","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1007\/s12035-018-1411-3","article-title":"Neuronal expression of UBQLN2(P497H) exacerbates TDP-43 pathology in TDP-43(G348C) mice through interaction with ubiquitin","volume":"56","author":"Picher-Martel","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00737_bib27","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1093\/brain\/aww237","article-title":"Exosome secretion is a key pathway for clearance of pathological TDP-43","volume":"139","author":"Iguchi","year":"2016","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0031-9384(02)00979-4","article-title":"Stress-induced impairment of inhibitory avoidance learning in female neuromedin B receptor-deficient mice","volume":"78","author":"Yamada","year":"2003","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00737_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma \u00d7 spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev Dyn"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00737_bib30","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1007\/s10571-023-01423-8","article-title":"In vitro models of amyotrophic lateral sclerosis","volume":"43","author":"Zhou","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00737_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140248","article-title":"Inflammation induces TDP-43 mislocalization and aggregation","volume":"10","author":"Correia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00737_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.611601","article-title":"TDP-43 mutation affects stress granule dynamics in differentiated NSC-34 motoneuron-like cells","volume":"9","author":"Ding","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00737_bib33","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1084\/jem.20111313","article-title":"Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB-mediated pathogenic pathways","volume":"208","author":"Swarup","year":"2011","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s13311-016-0499-2","article-title":"Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration","volume":"14","author":"Dutta","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00737_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/glia.24531","article-title":"Chronically activated microglia in ALS gradually lose their immune functions and develop unconventional proteome","volume":"72","author":"Barreto-N\u00fa\u00f1ez","year":"2024","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00737_bib36","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.celrep.2017.11.008","article-title":"Cellular and molecular anatomy of the human neuromuscular junction","volume":"21","author":"Jones","year":"2017","journal-title":"Cell Rep"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00737_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140420","article-title":"Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons","volume":"5","author":"Pozzi","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00737_bib38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"issue":"49","key":"10.1016\/j.neurot.2025.e00737_bib39","doi-asserted-by":"crossref","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","article-title":"Antibody uptake into neurons occurs primarily via clathrin-dependent Fc\u03b3 receptor endocytosis and is a prerequisite for acute tau protein clearance","volume":"288","author":"Congdon","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00737_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-015-0212-4","article-title":"Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS","volume":"3","author":"Mitchell","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"3-4","key":"10.1016\/j.neurot.2025.e00737_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0361-9230(93)90267-F","article-title":"Selective vulnerability of alpha motor neurons in ALS: relation to autoantibodies toward acetylcholinesterase (AChE) in ALS patients","volume":"30","author":"Conradi","year":"1993","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp Neurol"},{"issue":"51","key":"10.1016\/j.neurot.2025.e00737_bib43","doi-asserted-by":"crossref","first-page":"E8316","DOI":"10.1073\/pnas.1605210113","article-title":"Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS","volume":"113","author":"Lalancette-Hebert","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/exnr.1998.6758","article-title":"Selective loss of alpha motoneurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis","volume":"150","author":"Mohajeri","year":"1998","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00737_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/brb3.142","article-title":"Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion","volume":"3","author":"Vinsant","year":"2013","journal-title":"Brain Behav"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41598-020-80370-6","article-title":"Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS","volume":"11","author":"Brodovitch","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00737_bib47","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.4103\/1673-5374.308072","article-title":"Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives","volume":"16","author":"Falzone","year":"2021","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neurot.2025.e00737_bib48","first-page":"1","article-title":"Neurofilaments in health and disease","volume":"vol. 61","author":"Julien","year":"1998"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00308955","article-title":"Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis","volume":"79","author":"Mizusawa","year":"1989","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00737_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF00308716","article-title":"Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells","volume":"79","author":"Sobue","year":"1990","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurot.2025.e00737_bib52","article-title":"Withaferin-A treatment alleviates TAR DNA-binding Protein-43 pathology and improves cognitive function in a mouse model of FTLD","author":"Kumar","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00737_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","article-title":"Signaling by antibodies: recent progress","volume":"35","author":"Bournazos","year":"2017","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00737_bib54","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00737_bib55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","article-title":"Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy","volume":"21","author":"Spiller","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2025.e00737_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer's Disease, Parkinson's Disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00737_bib57","first-page":"305","article-title":"Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling","volume":"1","author":"Mizwicki","year":"2012","journal-title":"Am J Neurodegener Dis"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00737_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28553","article-title":"Serum cytokines profile changes in amyotrophic lateral sclerosis","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"issue":"10107","key":"10.1016\/j.neurot.2025.e00737_bib59","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00737_bib60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jnr.10271","article-title":"Immunoglobulin Fc\u03b3 receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons","volume":"69","author":"Mohamed","year":"2002","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12017-009-8099-5","article-title":"Involvement of Fc receptors in disorders of the central nervous system","volume":"12","author":"Okun","year":"2010","journal-title":"NeuroMolecular Med"},{"key":"10.1016\/j.neurot.2025.e00737_bib63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnins.2014.00235","article-title":"New roles for Fc receptors in neurodegeneration-the impact on immunotherapy for Alzheimer's Disease","volume":"8","author":"Fuller","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2025.e00737_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01139","article-title":"The role of antibodies and their receptors in protection against ordered protein assembly in neurodegeneration","volume":"10","author":"Katsinelos","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(93)90060-C","article-title":"Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease","volume":"48","author":"Peress","year":"1993","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1167\/iovs.13-11821","article-title":"Fc\u03b3 receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration","volume":"55","author":"Murinello","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00737_bib67","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.4049\/jimmunol.130.3.1210","article-title":"Interferon-induced enhancement of macrophage Fc receptor expression: beta-interferon treatment of C3H\/HeJ macrophages results in increased numbers and density of Fc receptors","volume":"130","author":"Vogel","year":"1983","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00737_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.febslet.2013.01.038","article-title":"Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function","volume":"587","author":"Chang","year":"2013","journal-title":"FEBS Lett"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00737_bib69","doi-asserted-by":"crossref","first-page":"14886","DOI":"10.1074\/jbc.M113.451849","article-title":"Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43)","volume":"288","author":"Shodai","year":"2013","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib70","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047548","article-title":"TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy","volume":"14","author":"Atkinson","year":"2021","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib71","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mcn.2007.03.007","article-title":"TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein","volume":"35","author":"Strong","year":"2007","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00420-5","article-title":"Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS\/FTD","volume":"16","author":"Kumar","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40035-022-00331-z","article-title":"TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis","volume":"11","author":"L\u00e9pine","year":"2022","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib74","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1038\/s41467-021-27221-8","article-title":"Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins","volume":"12","author":"Altman","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00737_bib75","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-020-02205-y","article-title":"TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons","volume":"140","author":"Nagano","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"Pt 3","key":"10.1016\/j.neurot.2025.e00737_bib76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.brainresbull.2016.09.002","article-title":"Specialized roles of neurofilament proteins in synapses: relevance to neuropsychiatric disorders","volume":"126","author":"Yuan","year":"2016","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41398-018-0194-7","article-title":"Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors","volume":"8","author":"Yuan","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00737_bib78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00737_bib79","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4103\/1673-5374.255975","article-title":"Interleukin-4 affects microglial autophagic flux","volume":"14","author":"Tang","year":"2019","journal-title":"Neural Regen Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib80","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.neurot.2025.e00737_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00737_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183207","article-title":"Platycodigenin as potential drug candidate for Alzheimer's Disease via modulating microglial polarization and neurite regeneration","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-A\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.neurot.2025.e00737_bib85","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","article-title":"TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome","volume":"273","author":"Zhao","year":"2015","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-019-0341-5","article-title":"Wild-type Cu\/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis","volume":"14","author":"Tokuda","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00737_bib87","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/00207454.2013.848440","article-title":"Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barr\u00e9 syndrome by quantitative determination of TDP-43 in cerebrospinal fluid","volume":"124","author":"Hosokawa","year":"2014","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00737_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.50943","article-title":"Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS","author":"Kasai","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00737_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/17482968.2010.541263","article-title":"Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value","volume":"12","author":"Noto","year":"2011","journal-title":"Amyotrophic Lateral Scler : Off Publ World Fed Neurol Res Group Motor Neuron Dis"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00737_bib91","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","article-title":"TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"65","author":"Steinacker","year":"2008","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00737_bib92","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jnnp-2013-305972","article-title":"Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation","volume":"85","author":"Su\u00e1rez-Calvet","year":"2014","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00737_bib93","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad306","article-title":"Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF","volume":"5","author":"Audrain","year":"2023","journal-title":"Brain Commun"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00737_bib94","doi-asserted-by":"crossref","first-page":"fcaa121","DOI":"10.1093\/braincomms\/fcaa121","article-title":"Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies","volume":"2","author":"Ng Kee Kwong","year":"2020","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurot.2025.e00737_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.647895","article-title":"40 years of CSF toxicity studies in ALS: what have we learnt about ALS pathophysiology?","volume":"14","author":"Ng Kee Kwong","year":"2021","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00737_bib96","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2023.12.003","article-title":"The sense of antisense therapies in ALS","volume":"30","author":"Van Daele","year":"2024","journal-title":"Trends Mol Med"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:49:50Z","timestamp":1772894990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925002156"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00737","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00737"}}